Cargando…

Intravenous immunoglobulin in the treatment of drug rash eosinophilia and systemic symptoms caused by phenytoin

A 32 year old Asian female on 300 mg per day of phenytoin following meningioma excision developed a fever with a diffuse maculopapular rash, lymphadenopathy and splenomegaly after12 days. A diagnosis of DRESS (Drug Rash Eosinophilia and Systemic Symptoms) syndrome was made. Patient was started on pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Santhamoorthy, Ponnusamy, Alexander, K John, Alshubaili, Asmahan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548378/
https://www.ncbi.nlm.nih.gov/pubmed/23349605
http://dx.doi.org/10.4103/0972-2327.104348
_version_ 1782256318955913216
author Santhamoorthy, Ponnusamy
Alexander, K John
Alshubaili, Asmahan
author_facet Santhamoorthy, Ponnusamy
Alexander, K John
Alshubaili, Asmahan
author_sort Santhamoorthy, Ponnusamy
collection PubMed
description A 32 year old Asian female on 300 mg per day of phenytoin following meningioma excision developed a fever with a diffuse maculopapular rash, lymphadenopathy and splenomegaly after12 days. A diagnosis of DRESS (Drug Rash Eosinophilia and Systemic Symptoms) syndrome was made. Patient was started on prednisolone at a dose of 1 mg/kg but since there was further deterioration in her condition, intravenous immunoglobulin was started. Clinical and blood parameters began to improve by the next day with liver functions returning to normal by the third week. DRESS syndrome is a drug hypersensitivity syndrome which can be fatal and therefore needs to be recognized early for the appropriate treatment to be started. The use of Intravenous immunoglobulins is anecdotal and the dramatic improvement noted in this case indicates that it is another treatment choice. The case and a brief review of the literature are discussed.
format Online
Article
Text
id pubmed-3548378
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-35483782013-01-24 Intravenous immunoglobulin in the treatment of drug rash eosinophilia and systemic symptoms caused by phenytoin Santhamoorthy, Ponnusamy Alexander, K John Alshubaili, Asmahan Ann Indian Acad Neurol Case Report A 32 year old Asian female on 300 mg per day of phenytoin following meningioma excision developed a fever with a diffuse maculopapular rash, lymphadenopathy and splenomegaly after12 days. A diagnosis of DRESS (Drug Rash Eosinophilia and Systemic Symptoms) syndrome was made. Patient was started on prednisolone at a dose of 1 mg/kg but since there was further deterioration in her condition, intravenous immunoglobulin was started. Clinical and blood parameters began to improve by the next day with liver functions returning to normal by the third week. DRESS syndrome is a drug hypersensitivity syndrome which can be fatal and therefore needs to be recognized early for the appropriate treatment to be started. The use of Intravenous immunoglobulins is anecdotal and the dramatic improvement noted in this case indicates that it is another treatment choice. The case and a brief review of the literature are discussed. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3548378/ /pubmed/23349605 http://dx.doi.org/10.4103/0972-2327.104348 Text en Copyright: © Annals of Indian Academy of Neurology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Santhamoorthy, Ponnusamy
Alexander, K John
Alshubaili, Asmahan
Intravenous immunoglobulin in the treatment of drug rash eosinophilia and systemic symptoms caused by phenytoin
title Intravenous immunoglobulin in the treatment of drug rash eosinophilia and systemic symptoms caused by phenytoin
title_full Intravenous immunoglobulin in the treatment of drug rash eosinophilia and systemic symptoms caused by phenytoin
title_fullStr Intravenous immunoglobulin in the treatment of drug rash eosinophilia and systemic symptoms caused by phenytoin
title_full_unstemmed Intravenous immunoglobulin in the treatment of drug rash eosinophilia and systemic symptoms caused by phenytoin
title_short Intravenous immunoglobulin in the treatment of drug rash eosinophilia and systemic symptoms caused by phenytoin
title_sort intravenous immunoglobulin in the treatment of drug rash eosinophilia and systemic symptoms caused by phenytoin
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548378/
https://www.ncbi.nlm.nih.gov/pubmed/23349605
http://dx.doi.org/10.4103/0972-2327.104348
work_keys_str_mv AT santhamoorthyponnusamy intravenousimmunoglobulininthetreatmentofdrugrasheosinophiliaandsystemicsymptomscausedbyphenytoin
AT alexanderkjohn intravenousimmunoglobulininthetreatmentofdrugrasheosinophiliaandsystemicsymptomscausedbyphenytoin
AT alshubailiasmahan intravenousimmunoglobulininthetreatmentofdrugrasheosinophiliaandsystemicsymptomscausedbyphenytoin